SE431755B - Forfarande for framstellning av nya acylderivat av cefalosporiner - Google Patents

Forfarande for framstellning av nya acylderivat av cefalosporiner

Info

Publication number
SE431755B
SE431755B SE7506908A SE7506908A SE431755B SE 431755 B SE431755 B SE 431755B SE 7506908 A SE7506908 A SE 7506908A SE 7506908 A SE7506908 A SE 7506908A SE 431755 B SE431755 B SE 431755B
Authority
SE
Sweden
Prior art keywords
cephalosporines
procedure
preparation
acyl derivatives
new acyl
Prior art date
Application number
SE7506908A
Other languages
English (en)
Swedish (sv)
Other versions
SE7506908L (sv
Inventor
M Montavon
R Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7506908L publication Critical patent/SE7506908L/xx
Publication of SE431755B publication Critical patent/SE431755B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7506908A 1974-06-21 1975-06-16 Forfarande for framstellning av nya acylderivat av cefalosporiner SE431755B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (2)

Publication Number Publication Date
SE7506908L SE7506908L (sv) 1975-12-22
SE431755B true SE431755B (sv) 1984-02-27

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7506908A SE431755B (sv) 1974-06-21 1975-06-16 Forfarande for framstellning av nya acylderivat av cefalosporiner

Country Status (25)

Country Link
JP (1) JPS625917B2 (da)
AT (1) AT337897B (da)
AU (1) AU498387B2 (da)
BE (1) BE830455A (da)
BR (1) BR7503782A (da)
CA (1) CA1111021A (da)
CH (1) CH609989A5 (da)
CU (1) CU34293A (da)
DD (1) DD121113A5 (da)
DE (1) DE2527291A1 (da)
DK (2) DK153155C (da)
FI (1) FI751815A (da)
FR (1) FR2275215A1 (da)
GB (1) GB1471804A (da)
HU (1) HU170576B (da)
IE (1) IE41888B1 (da)
IL (1) IL47299A (da)
LU (1) LU72771A1 (da)
NL (1) NL180665C (da)
NO (1) NO752202L (da)
NZ (1) NZ177508A (da)
PH (1) PH13030A (da)
SE (1) SE431755B (da)
SU (2) SU635873A3 (da)
ZA (1) ZA753086B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
CN1531598A (zh) * 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 制备头孢菌素衍生物的酶促方法
PT2250156E (pt) 2008-03-05 2015-09-09 Merck Patent Gmbh Derivados de pirazinona como estimuladores da secreção de insulina, métodos para a sua obtenção e utilização destes para o tratamento de diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
DK453687D0 (da) 1987-08-28
DD121113A5 (da) 1976-07-12
DK153155B (da) 1988-06-20
FR2275215A1 (fr) 1976-01-16
FI751815A (da) 1975-12-22
DK155329C (da) 1989-08-07
NO752202L (da) 1975-12-23
DK271975A (da) 1975-12-22
IE41888L (en) 1975-12-21
DK153155C (da) 1988-10-31
DK155329B (da) 1989-03-28
NL180665C (nl) 1987-04-01
AU498387B2 (en) 1979-03-08
JPS625917B2 (da) 1987-02-07
CH609989A5 (en) 1979-03-30
BR7503782A (pt) 1976-07-06
GB1471804A (en) 1977-04-27
HU170576B (da) 1977-07-28
DK453687A (da) 1987-08-28
IL47299A0 (en) 1976-10-31
BE830455A (fr) 1975-12-22
SE7506908L (sv) 1975-12-22
NL180665B (nl) 1986-11-03
IE41888B1 (en) 1980-04-23
AU8191275A (en) 1976-12-09
NL7507390A (nl) 1975-12-23
NZ177508A (en) 1978-04-03
ZA753086B (en) 1976-04-28
ATA476975A (de) 1976-11-15
CU34293A (es) 1979-01-16
JPS5113793A (da) 1976-02-03
LU72771A1 (da) 1977-03-04
AT337897B (de) 1977-07-25
PH13030A (en) 1979-11-15
SU589921A3 (ru) 1978-01-25
FR2275215B1 (da) 1980-05-16
DE2527291C2 (da) 1988-01-14
CA1111021A (en) 1981-10-20
IL47299A (en) 1979-01-31
DE2527291A1 (de) 1976-01-08
SU635873A3 (ru) 1978-11-30

Similar Documents

Publication Publication Date Title
SE464580B (sv) Foerfarande foer framstaellning av nya cefalosporinderivat
SE464581B (sv) Foerfarande foer famstaellning av nya cefalosporinderivat
SE7808204L (sv) Forfarande for framstellning av nya cefalosporiner
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
SE7513085L (sv) Forfarande for framstellning av etrar
SE426828B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner eller 6beta-acylamino-6alfa-alkoxipenicilliner
SE416731B (sv) Forfarande for framstellning av nya penicilliner
SE431548B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE431755B (sv) Forfarande for framstellning av nya acylderivat av cefalosporiner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE7507481L (sv) Forfarande for framstellning av nya cefalosporinderivat.
SE7510833L (sv) Forfarande for framstellning av nya cefalosporinderivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE435716B (sv) Forfarande for framstellning av nya penicilliner
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7506908-8

Effective date: 19940110

Format of ref document f/p: F